Zymeworks Stock Quote ZYME - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

9.06

Bid

8.90

Ask

9.62

Volume

879,258

8.88 Day's Range 9.33

0.00 52 Week Range 0.00

Market Cap

453.754M

Previous Close

9.12

Open

9.08

Last Trade

316300

9.06

(priorref)

Last Trade Time

Financial Volume

$ 8,014,286

VWAP

9.1148

Average Volume (3m)

Shares Outstanding

70,568,222

Dividend Yield

PE Ratio

-3.82

Earnings Per Share (EPS)

-1.68

Revenue

76.3M

Net Profit

-118.67M

Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enable precise engineering of differentiat... Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enable precise engineering of differentiated product candidates. Its lead clinical candidate, zanidatamab, is a novel Azymetric HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. The company is also advancing a deep preclinical pipeline in oncology and other therapeutic areas. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.zymeworks.com

Headquarters

North Vancouver, British Columbia, Can

Founded

1970

Zymeworks Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ZYME. The last closing price for Zymeworks was $9.12. Over the last year, Zymeworks shares have traded in a share price range of $ 0.00 to $ 0.00.

Zymeworks currently has 70,568,222 shares outstanding. The market capitalization of Zymeworks is $453.75 million. Zymeworks has a price to earnings ratio (PE ratio) of -3.82.

Zymeworks Provides Corporate Update and Reports First Quarter 2024 Financial Results

Reported $420.5 million in cash resources as of March 31, 2024, which when combined with certain anticipated regulatory milestone payments provides projected cash runway into 2H 2027Completion of...

Zymeworks Announces Participation in Upcoming Investor Conferences

VANCOUVER, British Columbia, April 30, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional...

Zymeworks To Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024

VANCOUVER, British Columbia, April 11, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional...

Zymeworks Presents New Data from Multiple Preclinical Development Programs at 2024 American Association for Cancer Research Annual Meeting

VANCOUVER, British Columbia, April 08, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
REBNReborn Coffee Inc	$ 3.14 (81.50%)	109.96M
SGDSafe and Green Development Corporation	$ 0.62 (58.81%)	70.08M
INODInnodata Inc	$ 10.50 (55.44%)	19.16M
ISUNiSun Inc	$ 0.1958 (48.33%)	135.23M
CRCTCricut Inc	$ 8.16 (47.56%)	7.86M
TMCITreace Medical Concepts Inc	$ 4.19 (-62.32%)	15.64M
MCRBSeres Therapeutics Inc	$ 0.74 (-33.33%)	15.05M
TOIIWOncology Institute Inc	$ 0.1168 (-32.09%)	122.56k
TRIPTripAdvisor Inc	$ 18.16 (-28.73%)	27.68M
SIGASIGA Technologies Inc	$ 7.50 (-28.30%)	4.17M
ISUNiSun Inc	$ 0.1958 (48.33%)	135.23M
REBNReborn Coffee Inc	$ 3.14 (81.50%)	109.96M
SQQQProShares UltraPro Short QQQ	$ 10.74 (0.19%)	100.71M
NKLANikola Corporation	$ 0.5791 (-3.95%)	85.64M
FCELFuelCell Energy Inc	$ 0.76 (-3.74%)	84.39M